Loading…

Chalcone and its analogs: Therapeutic and diagnostic applications in Alzheimer’s disease

[Display omitted] Chalcone [(E)-1,3-diphenyl-2-propene-1-one], a small molecule with α, β unsaturated carbonyl group is a precursor or component of many natural flavonoids and isoflavonoids. It is one of the privileged structures in medicinal chemistry. It possesses a wide range of biological activi...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic chemistry 2021-03, Vol.108, p.104681-104681, Article 104681
Main Authors: Thapa, Pritam, Upadhyay, Sunil P., Suo, William Z., Singh, Vikas, Gurung, Prajwal, Lee, Eung Seok, Sharma, Ram, Sharma, Mukut
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c529t-5218eaec654377dc04436ec5b756ea7ef3112ebcf901c069b37221dbc540492c3
cites cdi_FETCH-LOGICAL-c529t-5218eaec654377dc04436ec5b756ea7ef3112ebcf901c069b37221dbc540492c3
container_end_page 104681
container_issue
container_start_page 104681
container_title Bioorganic chemistry
container_volume 108
creator Thapa, Pritam
Upadhyay, Sunil P.
Suo, William Z.
Singh, Vikas
Gurung, Prajwal
Lee, Eung Seok
Sharma, Ram
Sharma, Mukut
description [Display omitted] Chalcone [(E)-1,3-diphenyl-2-propene-1-one], a small molecule with α, β unsaturated carbonyl group is a precursor or component of many natural flavonoids and isoflavonoids. It is one of the privileged structures in medicinal chemistry. It possesses a wide range of biological activities encouraging many medicinal chemists to study this scaffold for its usefulness to oncology, infectious diseases, virology and neurodegenerative diseases including Alzheimer’s disease (AD). Small molecular size, convenient and cost-effective synthesis, and flexibility for modifications to modulate lipophilicity suitable for blood brain barrier (BBB) permeability make chalcones a preferred candidate for their therapeutic and diagnostic potential in AD. This review summarizes and highlights the importance of chalcone and its analogs as single target small therapeutic agents, multi-target directed ligands (MTDLs) as well as molecular imaging agents for AD. The information summarized here will guide many medicinal chemist and researchers involved in drug discovery to consider chalcone as a potential scaffold for the development of anti-AD agents including theranostics.
doi_str_mv 10.1016/j.bioorg.2021.104681
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7928223</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0045206821000572</els_id><sourcerecordid>2489262548</sourcerecordid><originalsourceid>FETCH-LOGICAL-c529t-5218eaec654377dc04436ec5b756ea7ef3112ebcf901c069b37221dbc540492c3</originalsourceid><addsrcrecordid>eNp9kc9u1DAQxi0EokvhDRDKkUsWz8R2Eg5I1YoCUiUu5cLFciazu15l7WBnK5UTr8Hr9UlIu6XAhdPInm---fMT4iXIJUgwb3bLzseYNkuUCPOXMg08EguQrSwRUD4WCymVLlGa5kQ8y3knJYCqzVNxUlW6hgZgIb6utm6gGLhwoS_8lOfohrjJb4vLLSc38mHydJfsvduEmO-e4zh4cpOPIRc-FGfD9y37PaebHz_zLMzsMj8XT9ZuyPziPp6KL-fvL1cfy4vPHz6tzi5K0thOpUZo2DEZraq67kkqVRkm3dXasKt5XQEgd7RuJZA0bVfViNB3pJVULVJ1Kt4dfcdDt-eeOEzJDXZMfu_StY3O238zwW_tJl7ZusUGsZoNXt8bpPjtwHmye5-Jh8EFjodsUTUtGtSqmaXqKKUUc068fmgD0t5isTt7xGJvsdgjlrns1d8jPhT95vBnB54PdeU52UyeA3HvE9Nk--j_3-EXxWminw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2489262548</pqid></control><display><type>article</type><title>Chalcone and its analogs: Therapeutic and diagnostic applications in Alzheimer’s disease</title><source>ScienceDirect Freedom Collection</source><creator>Thapa, Pritam ; Upadhyay, Sunil P. ; Suo, William Z. ; Singh, Vikas ; Gurung, Prajwal ; Lee, Eung Seok ; Sharma, Ram ; Sharma, Mukut</creator><creatorcontrib>Thapa, Pritam ; Upadhyay, Sunil P. ; Suo, William Z. ; Singh, Vikas ; Gurung, Prajwal ; Lee, Eung Seok ; Sharma, Ram ; Sharma, Mukut</creatorcontrib><description>[Display omitted] Chalcone [(E)-1,3-diphenyl-2-propene-1-one], a small molecule with α, β unsaturated carbonyl group is a precursor or component of many natural flavonoids and isoflavonoids. It is one of the privileged structures in medicinal chemistry. It possesses a wide range of biological activities encouraging many medicinal chemists to study this scaffold for its usefulness to oncology, infectious diseases, virology and neurodegenerative diseases including Alzheimer’s disease (AD). Small molecular size, convenient and cost-effective synthesis, and flexibility for modifications to modulate lipophilicity suitable for blood brain barrier (BBB) permeability make chalcones a preferred candidate for their therapeutic and diagnostic potential in AD. This review summarizes and highlights the importance of chalcone and its analogs as single target small therapeutic agents, multi-target directed ligands (MTDLs) as well as molecular imaging agents for AD. The information summarized here will guide many medicinal chemist and researchers involved in drug discovery to consider chalcone as a potential scaffold for the development of anti-AD agents including theranostics.</description><identifier>ISSN: 0045-2068</identifier><identifier>EISSN: 1090-2120</identifier><identifier>DOI: 10.1016/j.bioorg.2021.104681</identifier><identifier>PMID: 33571811</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Alzheimer Disease - diagnosis ; Alzheimer Disease - drug therapy ; Alzheimer Disease - metabolism ; Alzheimer’s disease ; Amyloid beta inhibition ; Animals ; Blood-Brain Barrier - drug effects ; Blood-Brain Barrier - metabolism ; Chalcone ; Chalcone - analogs &amp; derivatives ; Chalcone - chemistry ; Chalcone - therapeutic use ; Cholinesterase inhibitors ; Humans ; Molecular probes ; Molecular Structure ; Multi-target directed ligands ; Neuroinflammation ; Theranostic</subject><ispartof>Bioorganic chemistry, 2021-03, Vol.108, p.104681-104681, Article 104681</ispartof><rights>2021</rights><rights>Published by Elsevier Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c529t-5218eaec654377dc04436ec5b756ea7ef3112ebcf901c069b37221dbc540492c3</citedby><cites>FETCH-LOGICAL-c529t-5218eaec654377dc04436ec5b756ea7ef3112ebcf901c069b37221dbc540492c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,315,786,790,891,27957,27958</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33571811$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Thapa, Pritam</creatorcontrib><creatorcontrib>Upadhyay, Sunil P.</creatorcontrib><creatorcontrib>Suo, William Z.</creatorcontrib><creatorcontrib>Singh, Vikas</creatorcontrib><creatorcontrib>Gurung, Prajwal</creatorcontrib><creatorcontrib>Lee, Eung Seok</creatorcontrib><creatorcontrib>Sharma, Ram</creatorcontrib><creatorcontrib>Sharma, Mukut</creatorcontrib><title>Chalcone and its analogs: Therapeutic and diagnostic applications in Alzheimer’s disease</title><title>Bioorganic chemistry</title><addtitle>Bioorg Chem</addtitle><description>[Display omitted] Chalcone [(E)-1,3-diphenyl-2-propene-1-one], a small molecule with α, β unsaturated carbonyl group is a precursor or component of many natural flavonoids and isoflavonoids. It is one of the privileged structures in medicinal chemistry. It possesses a wide range of biological activities encouraging many medicinal chemists to study this scaffold for its usefulness to oncology, infectious diseases, virology and neurodegenerative diseases including Alzheimer’s disease (AD). Small molecular size, convenient and cost-effective synthesis, and flexibility for modifications to modulate lipophilicity suitable for blood brain barrier (BBB) permeability make chalcones a preferred candidate for their therapeutic and diagnostic potential in AD. This review summarizes and highlights the importance of chalcone and its analogs as single target small therapeutic agents, multi-target directed ligands (MTDLs) as well as molecular imaging agents for AD. The information summarized here will guide many medicinal chemist and researchers involved in drug discovery to consider chalcone as a potential scaffold for the development of anti-AD agents including theranostics.</description><subject>Alzheimer Disease - diagnosis</subject><subject>Alzheimer Disease - drug therapy</subject><subject>Alzheimer Disease - metabolism</subject><subject>Alzheimer’s disease</subject><subject>Amyloid beta inhibition</subject><subject>Animals</subject><subject>Blood-Brain Barrier - drug effects</subject><subject>Blood-Brain Barrier - metabolism</subject><subject>Chalcone</subject><subject>Chalcone - analogs &amp; derivatives</subject><subject>Chalcone - chemistry</subject><subject>Chalcone - therapeutic use</subject><subject>Cholinesterase inhibitors</subject><subject>Humans</subject><subject>Molecular probes</subject><subject>Molecular Structure</subject><subject>Multi-target directed ligands</subject><subject>Neuroinflammation</subject><subject>Theranostic</subject><issn>0045-2068</issn><issn>1090-2120</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kc9u1DAQxi0EokvhDRDKkUsWz8R2Eg5I1YoCUiUu5cLFciazu15l7WBnK5UTr8Hr9UlIu6XAhdPInm---fMT4iXIJUgwb3bLzseYNkuUCPOXMg08EguQrSwRUD4WCymVLlGa5kQ8y3knJYCqzVNxUlW6hgZgIb6utm6gGLhwoS_8lOfohrjJb4vLLSc38mHydJfsvduEmO-e4zh4cpOPIRc-FGfD9y37PaebHz_zLMzsMj8XT9ZuyPziPp6KL-fvL1cfy4vPHz6tzi5K0thOpUZo2DEZraq67kkqVRkm3dXasKt5XQEgd7RuJZA0bVfViNB3pJVULVJ1Kt4dfcdDt-eeOEzJDXZMfu_StY3O238zwW_tJl7ZusUGsZoNXt8bpPjtwHmye5-Jh8EFjodsUTUtGtSqmaXqKKUUc068fmgD0t5isTt7xGJvsdgjlrns1d8jPhT95vBnB54PdeU52UyeA3HvE9Nk--j_3-EXxWminw</recordid><startdate>20210301</startdate><enddate>20210301</enddate><creator>Thapa, Pritam</creator><creator>Upadhyay, Sunil P.</creator><creator>Suo, William Z.</creator><creator>Singh, Vikas</creator><creator>Gurung, Prajwal</creator><creator>Lee, Eung Seok</creator><creator>Sharma, Ram</creator><creator>Sharma, Mukut</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20210301</creationdate><title>Chalcone and its analogs: Therapeutic and diagnostic applications in Alzheimer’s disease</title><author>Thapa, Pritam ; Upadhyay, Sunil P. ; Suo, William Z. ; Singh, Vikas ; Gurung, Prajwal ; Lee, Eung Seok ; Sharma, Ram ; Sharma, Mukut</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c529t-5218eaec654377dc04436ec5b756ea7ef3112ebcf901c069b37221dbc540492c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Alzheimer Disease - diagnosis</topic><topic>Alzheimer Disease - drug therapy</topic><topic>Alzheimer Disease - metabolism</topic><topic>Alzheimer’s disease</topic><topic>Amyloid beta inhibition</topic><topic>Animals</topic><topic>Blood-Brain Barrier - drug effects</topic><topic>Blood-Brain Barrier - metabolism</topic><topic>Chalcone</topic><topic>Chalcone - analogs &amp; derivatives</topic><topic>Chalcone - chemistry</topic><topic>Chalcone - therapeutic use</topic><topic>Cholinesterase inhibitors</topic><topic>Humans</topic><topic>Molecular probes</topic><topic>Molecular Structure</topic><topic>Multi-target directed ligands</topic><topic>Neuroinflammation</topic><topic>Theranostic</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Thapa, Pritam</creatorcontrib><creatorcontrib>Upadhyay, Sunil P.</creatorcontrib><creatorcontrib>Suo, William Z.</creatorcontrib><creatorcontrib>Singh, Vikas</creatorcontrib><creatorcontrib>Gurung, Prajwal</creatorcontrib><creatorcontrib>Lee, Eung Seok</creatorcontrib><creatorcontrib>Sharma, Ram</creatorcontrib><creatorcontrib>Sharma, Mukut</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Bioorganic chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thapa, Pritam</au><au>Upadhyay, Sunil P.</au><au>Suo, William Z.</au><au>Singh, Vikas</au><au>Gurung, Prajwal</au><au>Lee, Eung Seok</au><au>Sharma, Ram</au><au>Sharma, Mukut</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chalcone and its analogs: Therapeutic and diagnostic applications in Alzheimer’s disease</atitle><jtitle>Bioorganic chemistry</jtitle><addtitle>Bioorg Chem</addtitle><date>2021-03-01</date><risdate>2021</risdate><volume>108</volume><spage>104681</spage><epage>104681</epage><pages>104681-104681</pages><artnum>104681</artnum><issn>0045-2068</issn><eissn>1090-2120</eissn><notes>ObjectType-Article-1</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-3</notes><notes>content type line 23</notes><notes>ObjectType-Review-2</notes><abstract>[Display omitted] Chalcone [(E)-1,3-diphenyl-2-propene-1-one], a small molecule with α, β unsaturated carbonyl group is a precursor or component of many natural flavonoids and isoflavonoids. It is one of the privileged structures in medicinal chemistry. It possesses a wide range of biological activities encouraging many medicinal chemists to study this scaffold for its usefulness to oncology, infectious diseases, virology and neurodegenerative diseases including Alzheimer’s disease (AD). Small molecular size, convenient and cost-effective synthesis, and flexibility for modifications to modulate lipophilicity suitable for blood brain barrier (BBB) permeability make chalcones a preferred candidate for their therapeutic and diagnostic potential in AD. This review summarizes and highlights the importance of chalcone and its analogs as single target small therapeutic agents, multi-target directed ligands (MTDLs) as well as molecular imaging agents for AD. The information summarized here will guide many medicinal chemist and researchers involved in drug discovery to consider chalcone as a potential scaffold for the development of anti-AD agents including theranostics.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>33571811</pmid><doi>10.1016/j.bioorg.2021.104681</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0045-2068
ispartof Bioorganic chemistry, 2021-03, Vol.108, p.104681-104681, Article 104681
issn 0045-2068
1090-2120
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7928223
source ScienceDirect Freedom Collection
subjects Alzheimer Disease - diagnosis
Alzheimer Disease - drug therapy
Alzheimer Disease - metabolism
Alzheimer’s disease
Amyloid beta inhibition
Animals
Blood-Brain Barrier - drug effects
Blood-Brain Barrier - metabolism
Chalcone
Chalcone - analogs & derivatives
Chalcone - chemistry
Chalcone - therapeutic use
Cholinesterase inhibitors
Humans
Molecular probes
Molecular Structure
Multi-target directed ligands
Neuroinflammation
Theranostic
title Chalcone and its analogs: Therapeutic and diagnostic applications in Alzheimer’s disease
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-22T01%3A47%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chalcone%20and%20its%20analogs:%20Therapeutic%20and%20diagnostic%20applications%20in%20Alzheimer%E2%80%99s%20disease&rft.jtitle=Bioorganic%20chemistry&rft.au=Thapa,%20Pritam&rft.date=2021-03-01&rft.volume=108&rft.spage=104681&rft.epage=104681&rft.pages=104681-104681&rft.artnum=104681&rft.issn=0045-2068&rft.eissn=1090-2120&rft_id=info:doi/10.1016/j.bioorg.2021.104681&rft_dat=%3Cproquest_pubme%3E2489262548%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c529t-5218eaec654377dc04436ec5b756ea7ef3112ebcf901c069b37221dbc540492c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2489262548&rft_id=info:pmid/33571811&rfr_iscdi=true